We studied the interactions of the hypotensive drug, 2-hydroxyoleic acid (2OHOA), with model membranes using the techniques of DSC, 31P NMR and X-ray diffraction. We demonstrate that 2OHOA alters the thermotropic behaviour of 1,2-dielaidoyl-sn-glycero-3-phosphoethanolamine (DEPE), thereby promoting the formation of hexagonal phases (H(II)), despite stabilizing the lamellar phase (Lalpha). The lattice parameters of lamellar and non-lamellar structures were not altered by the presence of 2OHOA. The molecular bases underlying the alterations in membrane structure provoked by 2OHOA were analysed by comparing the effects produced by 2OHOA with the closely related fatty acids (FAs), oleic acid (OA) and elaidic acid (EA). The capacity of C-18 FAs to induce H(II)-phase formation followed the order OA > 2OHOA > EA. Furthermore, while 2OHOA stabilized the Lalpha phase, OA destabilized it. The net negative charge of 2OHOA at physiological pH (approximately 7.4) influenced its effect on membrane structure. By analysing the molecular architecture of 2OHOA in DEPE monolayers, interactions between the carboxylate groups of 2OHOA and the amine groups of DEPE were observed, as well as between the 2-hydroxyl group of the FA and the carbonyl oxygen of the phospholipid acyl chain. These structural characteristics provoked an increase in the P-to-N and P-to-P distances of neighbouring phospholipid headgroups in the presence of 2OHOA, with respect to those observed with OA and EA. The higher headgroup area at the lipid-water interface in presence of 2OHOA could account for the differential effect of this drug on the phase behaviour of DEPE membranes.

Download full-text PDF

Source
http://dx.doi.org/10.1080/09687680410001716835DOI Listing

Publication Analysis

Top Keywords

2ohoa
12
presence 2ohoa
12
hypotensive drug
8
drug 2-hydroxyoleic
8
2-hydroxyoleic acid
8
model membranes
8
membrane structure
8
acid
4
acid modifies
4
modifies structural
4

Similar Publications

Targeting the Notch-Furin axis with 2-hydroxyoleic acid: a key mechanism in glioblastoma therapy.

Cell Oncol (Dordr)

October 2024

R&D Department, Laminar Pharmaceuticals, C/Isaac Newton, Palma de Mallorca, 07121, Spain.

Article Synopsis
  • Glioblastomas (GBMs) are aggressive brain tumors that resist treatment; the study investigates the effects of 2OHOA, a drug currently in clinical trials, on the Notch signaling pathway associated with tumor growth.
  • 2OHOA was found to inhibit Notch2 and Notch3 through different mechanisms: it affects Notch2 processing by inactivating furin and downregulates Notch3 transcriptionally.
  • The research emphasizes that targeting Notch signaling may enhance 2OHOA's anticancer effects, presenting a potential new approach for GBM treatment.
View Article and Find Full Text PDF

2-Hydroxyoleic acid (2-OHOA) has gained attention as a membrane lipid therapy (MLT) anti-cancer drug. However, in the viewpoint of anti-cancer drug, 2-OHOA shows poor water solubility and its effectiveness still has space for improvement. Thus, this study aimed to overcome the problems by formulating 2-OHOA into liposome dosage form.

View Article and Find Full Text PDF
Article Synopsis
  • The study evaluates 2-OHOA, a synthetic lipid, in a Phase 1/2A trial to determine its safety, tolerability, and efficacy for treating gliomas and advanced solid tumors in 54 patients.
  • The trial found that 2-OHOA was well-tolerated at dosage levels, with common side effects being mild gastrointestinal issues, while establishing a recommended phase-2 dose of 12,000 mg daily.
  • Some patients, particularly those with high-grade gliomas, showed promising clinical benefits, with 24% experiencing significant positive responses, including one lasting over 2.5 years.
View Article and Find Full Text PDF

A potent nontoxic antitumor drug, 2-hydroxyoleic acid (, 2OHOA) used for membrane lipid therapy, was selected as a self-assembly inducer due to its ability to form nanoparticles (NPs) in water. For this purpose, it was conjugated with a series of anticancer drugs through a disulfide-containing linker to enhance cell penetration and to secure drug release inside the cell. The antiproliferative evaluation of the synthesized NP formulations against three human tumor cell lines (biphasic mesothelioma MSTO-211H, colorectal adenocarcinoma HT-29, and glioblastoma LN-229) showed that nanoassemblies - exhibit antiproliferative activity at micromolar and submicromolar concentrations.

View Article and Find Full Text PDF

The synthetic fatty acid 2-hydroxyoleic acid (2OHOA) has been extensively investigated as a cancer therapy mainly based on its regulation of membrane lipid composition and structure, activating various cell fate pathways. We discovered, additionally, that 2OHOA can uncouple oxidative phosphorylation, but this has never been demonstrated mechanistically. Here, we explored the effect of 2OHOA on mitochondria isolated by ultracentrifugation from U118MG glioblastoma cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!